Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Elliott

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
Frontiers in Oncology|March 25, 2021
Beginning Restorative Activities Very Early: Implementation of an Early Mobility Initiative in a Pediatric Onco-Critical Care UnitSaad Ghafoor, Kimberly Fan, Sarah Williams, et al.
The Oncologist|June 19, 2025
REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimensJeffrey Zhong, Albert Jang, Bashar Abuqayas, et al.
Cancer Discovery|February 26, 2026
A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancerMichelle A Tran, Byuri Angela Cho, Sudeh Izadmehr, et al.
European Urology Oncology|December 10, 2023
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerJacob J Orme, Fadi Taza, Navonil De Sarkar, et al.
Cancer Discovery|April 2, 2024
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET InhibitorsFederica Pecci, Seshiru Nakazawa, Biagio Ricciuti, et al.
Nature Communications|July 17, 2015
The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogrammingLiem Phan, Ping-Chieh Chou, Guermarie Velazquez-Torres, et al.
Nature Communications|August 19, 2025
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinomaAmin H Nassar, Chul Kim, Tolulope Adeyelu, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
Frontiers in Oncology|March 25, 2021
Beginning Restorative Activities Very Early: Implementation of an Early Mobility Initiative in a Pediatric Onco-Critical Care UnitSaad Ghafoor, Kimberly Fan, Sarah Williams, et al.
The Oncologist|June 19, 2025
REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimensJeffrey Zhong, Albert Jang, Bashar Abuqayas, et al.
Cancer Discovery|February 26, 2026
A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancerMichelle A Tran, Byuri Angela Cho, Sudeh Izadmehr, et al.
European Urology Oncology|December 10, 2023
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerJacob J Orme, Fadi Taza, Navonil De Sarkar, et al.
Cancer Discovery|April 2, 2024
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET InhibitorsFederica Pecci, Seshiru Nakazawa, Biagio Ricciuti, et al.
Nature Communications|July 17, 2015
The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogrammingLiem Phan, Ping-Chieh Chou, Guermarie Velazquez-Torres, et al.
Nature Communications|August 19, 2025
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinomaAmin H Nassar, Chul Kim, Tolulope Adeyelu, et al.
Pageof 16